DBV Technologies (DBVT) EBT Margin (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 162,558.00 |
| Dec 31, 2025 | -569,672.00 |
| Sep 30, 2025 | 165,485.00 |
| Jun 30, 2025 | 53,712.00 |
| Mar 31, 2025 | 111,504.00 |
| Dec 31, 2024 | -166,281.00 |
| Sep 30, 2024 | 1,263.00 |
| Jun 30, 2024 | -91,228.00 |
| Mar 31, 2024 | -181,398.00 |
| Dec 31, 2023 | 57,946.00 |
| Sep 30, 2023 | 35,344.00 |
| Jun 30, 2023 | -12,186.00 |
| Mar 31, 2023 | -394,773.00 |
| Dec 31, 2022 | 384,409.00 |
| Sep 30, 2022 | 67,329.00 |
| Jun 30, 2022 | -85,405.00 |
| Mar 31, 2022 | -18,723.00 |
| Dec 31, 2021 | 135,103.00 |
| Sep 30, 2021 | 27,269.00 |
| Jun 30, 2021 | -108,894.00 |
| Mar 31, 2021 | -425,979.00 |
| Dec 31, 2020 | 400,379.00 |
| Sep 30, 2020 | 59,088.00 |
| Jun 30, 2020 | -46,838.00 |
| Dec 31, 2018 | 195,138.00 |